Literature DB >> 16794186

A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function.

Zaza Khuchua1, Zou Yue, Lorene Batts, Arnold W Strauss.   

Abstract

Barth syndrome is an X-linked disorder characterized by cardiomyopathy, skeletal myopathy, neutropenia, organic aciduria, and growth retardation caused by mutations in tafazzin. The sequence similarity of tafazzin to acyltransferases suggests a role in mitochondrial phospholipid metabolism. To study the role of tafazzin in heart function and development, we created a knockdown zebrafish model. Zebrafish tafazzin mRNA is first evident at 7 hours post-fertilization (hpf). At 10 and 24 hpf, tafazzin mRNA is ubiquitous, with highest levels in the head. By 51 hpf, expression becomes cardiac restricted. The tafazzin knockdown created by antisense morpholino yolk injection resulted in dose-dependent lethality, severe developmental and growth retardation, marked bradycardia and pericardial effusions, and generalized edema, signs that resemble human Barth syndrome heart failure. This knockdown phenotype was rescued by concomitant injection of normal tafazzin mRNA. Abnormal cardiac development, with a linear, nonlooped heart, and hypomorphic tail and eye development proves that tafazzin is essential for overall zebrafish development, especially of the heart. The tafazzin knockdown zebrafish provides an animal model similar to Barth syndrome to analyze the severity of human mutants and to test potential treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794186     DOI: 10.1161/01.RES.0000233378.95325.ce

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  40 in total

1.  A new model system swims into focus: using the zebrafish to visualize intestinal metabolism in vivo.

Authors:  Juliana D Carten; Steven A Farber
Journal:  Clin Lipidol       Date:  2009-08-01

Review 2.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

3.  Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.

Authors:  Meghan S Soustek; Darin J Falk; Cathryn S Mah; Matthew J Toth; Michael Schlame; Alfred S Lewin; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

Review 4.  Mitochondrial dysfunctions in barth syndrome.

Authors:  Sagnika Ghosh; Donna M Iadarola; Writoban Basu Ball; Vishal M Gohil
Journal:  IUBMB Life       Date:  2019-02-11       Impact factor: 3.885

5.  A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.

Authors:  Wuhong Pei; Lisa E Kratz; Isa Bernardini; Raman Sood; Tohei Yokogawa; Heidi Dorward; Carla Ciccone; Richard I Kelley; Yair Anikster; Harold A Burgess; Marjan Huizing; Benjamin Feldman
Journal:  Development       Date:  2010-08-01       Impact factor: 6.868

Review 6.  Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.

Authors:  Nikita Ikon; Robert O Ryan
Journal:  Lipids       Date:  2017-01-09       Impact factor: 1.880

Review 7.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

Review 8.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

9.  AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.

Authors:  Silveli Suzuki-Hatano; Madhurima Saha; Skylar A Rizzo; Rachael L Witko; Bennett J Gosiker; Manashwi Ramanathan; Meghan S Soustek; Michael D Jones; Peter B Kang; Barry J Byrne; W Todd Cade; Christina A Pacak
Journal:  Hum Gene Ther       Date:  2018-10-03       Impact factor: 5.695

10.  Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy.

Authors:  David Hassel; Tillman Dahme; Jeanette Erdmann; Benjamin Meder; Andreas Huge; Monika Stoll; Steffen Just; Alexander Hess; Philipp Ehlermann; Dieter Weichenhan; Matthias Grimmler; Henrike Liptau; Roland Hetzer; Vera Regitz-Zagrosek; Christine Fischer; Peter Nürnberg; Heribert Schunkert; Hugo A Katus; Wolfgang Rottbauer
Journal:  Nat Med       Date:  2009-11-01       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.